Ann Arbor, MI, United States of America

Clifford Suhyun Cho

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovator Spotlight: Clifford Suhyun Cho**

Introduction

Clifford Suhyun Cho, based in Ann Arbor, MI, is a notable inventor recognized for his contributions in the field of medical technology. With a focus on advancing immunotherapy techniques, his work is pivotal in enhancing treatment options for patients suffering from cancer.

Latest Patents

Cho holds a patent for "Systems and methods for histotripsy immunosensitization," which outlines innovative systems and methods that integrate histotripsy and immunotherapy. This patent describes how histotripsy can be employed on target tissue volumes to lyse and solubilize them, effectively releasing tumor antigens. This process has the potential to evaluate the immune response and improve therapies by enabling the extraction of lysed and solubilized cells for developing immune therapies, including vaccines.

Career Highlights

Throughout his career, Clifford Suhyun Cho has collaborated with prestigious institutions, such as the University of Michigan and the United States Government, represented by the Department of Veterans Affairs. His work focuses significantly on medical innovations that aim to enhance the efficacy of cancer treatments.

Collaborations

Cho has worked alongside esteemed colleagues, including Zhen Xu, with whom he has developed groundbreaking strategies in histotripsy and immunotherapy. Their collaboration reflects a commitment to pushing the boundaries of current medical practices.

Conclusion

Clifford Suhyun Cho's contributions to medical technology through his patent on histotripsy immunosensitization mark a significant advancement in cancer treatment methodologies. His innovative approach demonstrates the vital intersection of engineering and medicine, aiming to provide effective solutions that may impact the future of cancer therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…